Literature DB >> 15812389

Predictive utility of the attached segment in the quality control of a cord blood graft.

Luciano Rodríguez1, Joan García, Sergi Querol.   

Abstract

The limited number of progenitor stem cells in umbilical cord blood (UCB) enforces the optimization and strict control of all the procedures involved in its therapeutic use--ie, collection, processing, cryopreservation, thawing, and transportation--to ensure graft potency at transplantation. For this reason, international UCB standards recommend storage of a cell sample attached to the UCB unit as a quantitative and functional control of the unit selected for transplantation. To validate the use of the sample attached to the UCB unit as a quality-control tool for the final product, UCB units (n = 20) stored in liquid nitrogen with the Bioarchive system were analyzed. The UCB units and their attached segments were thawed, and the number and viability of total nucleated cells, mononucleated cells, CD45 + cells, and CD34+ cells were determined, as were colony-forming cell counts. There was no significant difference between UCB units and segments for any of the parameters assessed. Additionally, the linear correlation coefficient (R2) in these paired samples was 0.85 and 0.78 for CD34+ cells and colony-forming cells, respectively. In conclusion, the cell sample in the tube segment physically linked to the transplant UCB bag predicts the total cell content and functionality of the unit and may serve as a source for final quality control of the UCB unit before transplantation.

Entities:  

Mesh:

Year:  2005        PMID: 15812389     DOI: 10.1016/j.bbmt.2004.12.333

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  6 in total

1.  Cord blood attached segment: is this a relevant quality control to predict a good hematopoietic stem cell graft?

Authors:  L Faivre; H Boucher; R Zerbib; T Domet; A Desproges; C Couzin; V Vanneaux; J Larghero; A Cras
Journal:  Bone Marrow Transplant       Date:  2017-07-10       Impact factor: 5.483

2.  Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.

Authors:  Duncan Purtill; Katherine Smith; Sean Devlin; Richard Meagher; Joann Tonon; Marissa Lubin; Doris M Ponce; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Cladd E Stevens; Juliet N Barker
Journal:  Blood       Date:  2014-09-02       Impact factor: 22.113

3.  The use of back-up units to enhance the safety of unrelated donor cord blood transplantation.

Authors:  Doris M Ponce; Marissa Lubin; Anne Marie Gonzales; Courtney Byam; Deborah Wells; Rosanna Ferrante; Glenn Heller; Sergio Giralt; Esperanza B Papadopoulos; Nancy A Kernan; Andromachi Scaradavou; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2012-01-11       Impact factor: 5.742

Review 4.  How I treat: the selection and acquisition of unrelated cord blood grafts.

Authors:  Juliet N Barker; Courtney Byam; Andromachi Scaradavou
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

5.  Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant.

Authors:  Eiman Hussein; Todd DeFor; John E Wagner; Darin Sumstad; Claudio G Brunstein; David H McKenna
Journal:  Transfusion       Date:  2019-11-22       Impact factor: 3.157

6.  Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units.

Authors:  John Patterson; Cally H Moore; Emily Palser; Jason C Hearn; Daniela Dumitru; Holli A Harper; Ivan N Rich
Journal:  J Transl Med       Date:  2015-03-18       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.